Mink Therapeutics Inc (INKT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -9,892 | -7,004 | -2,767 | -10,785 | -8,322 |
| Depreciation Amortization | 143 | 100 | 51 | 215 | 162 |
| Accounts payable and accrued liabilities | 959 | 578 | -69 | -1,182 | -1,557 |
| Other Working Capital | 2,819 | 1,758 | 591 | 460 | 481 |
| Other Operating Activity | 2,119 | 1,659 | 853 | 1,737 | 1,408 |
| Operating Cash Flow | $-3,851 | $-2,910 | $-1,341 | $-9,556 | $-7,828 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | 5,000 | 5,000 |
| Common Stock Issued | 13,547 | 1 | 1 | 5,820 | 5,820 |
| Financing Cash Flow | $13,547 | $1 | $1 | $10,820 | $10,820 |
| Exchange Rate Effect | 9 | 14 | -2 | -55 | -31 |
| Beginning Cash Position | 4,577 | 4,577 | 4,577 | 3,367 | 3,367 |
| End Cash Position | 14,281 | 1,682 | 3,235 | 4,577 | 6,328 |
| Net Cash Flow | $9,704 | $-2,895 | $-1,342 | $1,210 | $2,961 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,851 | -2,910 | -1,341 | -9,556 | -7,828 |
| Free Cash Flow | -3,851 | -2,910 | -1,341 | -9,556 | -7,828 |